Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: a systematic review and meta-analysis.

Overview

authors

Bewersdorf, Jan Philipp

Williams, Robert Thomas
Tallman, Martin S
Zeidan, Amer M
Stahl, Maximilian

publication date

November 1, 2020

published in

Haematologica Journal

Research

keywords

Cytarabine
Leukemia, Myeloid, Acute

Identity

PubMed Central ID

PMC7604631

Scopus Document Identifier

85085000743

Digital Object Identifier (DOI)

10.3324/haematol.2019.242826

PubMed ID

33131256

Additional Document Info

has global citation frequency

69

volume

105

issue

11